期刊文献+

培美曲塞治疗复治晚期非小细胞肺癌的临床分析

Clinical analysis of pemetrexed for recurrent advanced non-small cell lung cancer
下载PDF
导出
摘要 目的分析研究培美曲塞治疗复治晚期非小细胞肺癌的治疗效果。方法抽取本院收治的36例复治晚期非小细胞肺癌患者,给予患者采用培美曲塞治疗,回顾性分析患者临床资料。结果对36例患者实施治疗,可见本次研究与参考总样本之间治疗效果对比差异有统计学意义,P<0.05,不同病理实施治疗时,两组治疗效果无明显差异,P>0.05,差异无统计学意义。结论给予复治晚期非小细胞肺癌患者采用培美曲塞治疗,临床治疗效果显著。 Objective To analyze the curative effect of pemetrexed treatment in recurrent advanced non-small cell lung cancer. Methods Extraction of our hospital 36 cases of recurrent advanced non-small cell lung cancer patients, give patients treated with pemetrexed, patients with clinical data were retrospectively analyzed. Results 36 cases of patients with treatment, visible with reference to the research on the total sample treatment effect comparison between significant difference, P〈0.05 was statistically significant, different pathological treatment, no obvious difference was found between two groups of treatment effect, P&gt;0.05, no statistical significance. Conclusion Giving the retreatment advanced non-small cell lung cancer patients treated with pemetrexed, clinical effect is remarkable.
出处 《中国实用医药》 2014年第4期27-28,共2页 China Practical Medicine
关键词 培美曲塞 复治晚期 非小细胞肺癌 Pemetrexed Retreatment late Non-small cell lung cancer
  • 相关文献

参考文献3

二级参考文献17

  • 1张特,刘大海,王斌,李晓勇.恩度联合吉西他滨和顺铂二线方案治疗晚期非小细胞肺癌的近期疗效及安全性[J].中国全科医学,2009,12(11):969-971. 被引量:33
  • 2Calvert H.An Overview of Folate Metabolism:Features Relevant to the Action and Toxieities of Antifolate Antieaneer Agents[J].Semi Oncol,1999,26:3-10.
  • 3Hanna N,Shepherd F A,Fossella F V,et al.Randomized Pase Ⅲ Trial of Pemetrexed Versus Docetaxel in Patients with Non-small-cell Lung Cancer Previously Treated with Chemotherapy[J].J Clin Oncol,2004,22(9):1589-1597.
  • 4Therasse P,Arbuck S G,Eiscilhauer E A,et al.New Guidelines to Evaluate the Response to Treatment in Solid Turmor[J].J Natl Cancer Inst,2000,92(3):205-216.
  • 5Scagliotti G V,Parikh P,von Pawel J,et al.Phase Ⅲ Study Comparing Cisplatin Plus Gemcitabine with Cisplatin Plus Pemetrexed in Chemotherapy-naive Patients with Advanced-stage Non-small-cell Lung Cancer[J].J Clin Oncol Jul,2008,26(21):3543-3551.
  • 6Belani C P,Brodowicz T,Ciuleanu T,et al.Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care for Non-small-cell Lung Cancer:A Randomised,Double-blind,Phase 3 Study[J].Lancet,2009,374:1432-1440.
  • 7COHEN M H,JOHNSON J R,WANG Y C,et al. FDA Drug Approval Summary: Pemetrexed for injection (Alimta) for the treatment of non-small cell hmg cancer [J]. Oncologist, 2005,10(8 ): 363-368.
  • 8MANEGOLD C,GATZEMEIER U,VON PAWEL J,et al. Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, AL IMTA)and cisplatin:a multicenter phase II trial [J ]. Ann Oncol, 2000,11 (4):435.
  • 9SHEPHERD F A, DANCEY J, ARNOLD A,et al.Phase II study of pemetrexed disodium a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced non-small cell lung carcinoma[J ]. Cancer(Phila), 2001, 92 ( 3 ):595 - 600.
  • 10SMIT E F, MATYSON K, J VON PAWEL,et al. Alimta? (pemetrexed disodium) as second-line treatment of non-small cell lung cancer: A phase 11 Study [J ]. Ann Oncol, 2003, 14(6): 455-460.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部